Application of a hypoxia metric to investigate tumor mutational burden and cancer cell immunogenicity in vitro.

被引：0
|
作者：
Abou Khouzam, Raefa [1 ]
Zeinelabdin, Nagwa Ahmed [1 ]
Sharda, Mohak [2 ]
Nawafleh, Husam [1 ]
Mahmood, Ayda Shah [1 ]
Khan, Munazza Samar [1 ]
Venkatesh, Goutham Hassan [1 ]
Chouaib, Salem [1 ]
Rao, Shyama Prasad [3 ]
机构：
[1] Gulf Med Univ, Ajman, U Arab Emirates
[2] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India
[3] Yenepoya Univ, Yenepoya Res Ctr, Mangalore, India
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5679
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prevalence and mutational determinants of high tumor mutation burden in breast cancer
    Barroso-Sousa, R.
    Jain, E.
    Cohen, O.
    Kim, D.
    Buendia-Buendia, J.
    Winer, E.
    Lin, N.
    Tolaney, S. M.
    Wagle, N.
    ANNALS OF ONCOLOGY, 2020, 31 (03) : 387 - 394
  • [32] MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer
    Huang, Jiahao
    Liu, Haizhou
    Zhao, Yang
    Luo, Tao
    Liu, Jungang
    Liu, Junjie
    Pan, Xiaoyan
    Tang, Weizhong
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [33] Analytic validation of a pan-cancer tumor mutational burden assay
    Nesselbush, Monica
    Jones, Sian
    Keefer, Laurel
    Sengamalay, Naomi
    Velculescu, Victor
    Diaz, Luis
    Sausen, Mark
    Angiuoli, Samuel
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [34] Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer
    H. Kim
    Y. J. Heo
    Y. A. Cho
    S. Y. Kang
    S. Ahn
    K. -M. Kim
    Clinical and Translational Oncology, 2022, 24 : 556 - 567
  • [35] Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer
    Kim, H.
    Heo, Y. J.
    Cho, Y. A.
    Kang, S. Y.
    Ahn, S.
    Kim, K. M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (03): : 556 - 567
  • [36] Tumor Mutational Burden in Breast Cancer: Current Evidence, Challenges, and Opportunities
    Barroso-Sousa, Romualdo
    Pacifico, Jana Priscila
    Sammons, Sarah
    Tolaney, Sara M.
    CANCERS, 2023, 15 (15)
  • [37] Characterization of pancreatic cancer with ultra-low tumor mutational burden
    Taisuke Imamura
    Ryo Ashida
    Keiichi Ohshima
    Katsuhiko Uesaka
    Teiichi Sugiura
    Katsuhisa Ohgi
    Mihoko Yamada
    Shimpei Otsuka
    Keiichi Hatakeyama
    Takeshi Nagashima
    Takashi Sugino
    Kenichi Urakami
    Yasuto Akiyama
    Ken Yamaguchi
    Scientific Reports, 13
  • [38] Tumor mutational burden as a tissue-agnostic biomarker for cancer immunotherapy
    Sung, Winnie W. Y.
    Chow, James C. H.
    Cho, William C. S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (02) : 141 - 143
  • [39] Tumor mutational burden and immune signatures interplay in renal cell carcinoma
    Yakirevich, Evgeny
    Patel, Nimesh R.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [40] Pan-cancer landscape of clonal tumor mutational burden (cTMB)
    Parikh, A. R.
    Murugesan, K.
    Hopkins, J. F.
    Arshad, Z.
    Jin, D. X.
    Klempner, S. J.
    Fabrizio, D. A.
    Frampton, G. M.
    He, J.
    Montesion, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S582 - S583
12345